The MAPK8IP3 Knockout Raji Polyclonal Cells comprise a genetically heterogeneous population of Raji B lymphocytes edited by CRISPR/Cas9 to disrupt the MAPK8IP3 gene, encoding the JNK-interacting protein 3 (JIP3). This polyclonal knockout product provides a robust loss-of-function system for studying JIP3-dependent signaling and transport mechanisms without the biases of clonal selection, enabling representative population-level assays.
Raji cells, a human male EBV-positive Burkitt lymphoma B lymphocyte line, exhibit suspension lymphoblastoid growth and are extensively used in immunology and cancer research. Their derivation from a high-grade B-cell malignancy and persistent EBV infection provide a clinically relevant context for exploring oncogenic signaling, apoptotic regulation, and viral-host interactions. The suspension format facilitates high-throughput manipulation, including flow cytometry, co-culture systems, and biochemical fractionation.
MAPK8IP3 (JIP3) functions as a scaffold that organizes JNK MAP kinase pathway kinases, facilitating signal transmission from upstream stress and cytokine signals to downstream transcription factors. Activated by TNF-alpha, IL-1, and cellular stressors (UV, oxidative stress), JIP3 assembles complexes containing MAP3Ks (MEKK1, DLK), MAP2K4/MAP2K7, and JNK1/2/3, promoting c-Jun and ATF2 phosphorylation and AP-1-mediated transcription. Additionally, JIP3 links JNK signaling to kinesin-1 (KLC1) and dynein motors, regulating axonal transport and vesicular trafficking, and interacts with RAC1, ARF6, and APP, integrating cytoskeletal dynamics with stress responses.
In Raji B cells, JIP3 scaffolding is expected to govern JNK-dependent apoptosis and cytoskeletal organization, processes vital for lymphoma cell survival and migration. Knockout of MAPK8IP3 likely disrupts assembly of active JNK signaling modules, attenuating stress-induced apoptosis and potentially altering Bcl-2 family protein balance. Impairment of kinesin-mediated transport may further affect cell polarity and immune synapse formation. Given the EBV-positive background, this model may illuminate interactions between viral latent membrane proteins and JNK pathway components, contributing to lymphomagenesis research.
These polyclonal knockout cells support diverse investigations, including JNK signaling analysis in B-cell apoptosis via annexin V/PI flow cytometry, phospho-JNK/c-Jun Western blotting, and RT-qPCR for AP-1 target genes. Applications extend to co-immunoprecipitation mapping of residual JIP3 interactions, MTT-based proliferation assays, and Transwell migration studies. The model is valuable for drug target validation in the JNK pathway and for examining neurodevelopment-linked gene functions in a lymphoid malignancy context. For further information, contact Ascent Research.
